FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1489925511> ?p ?o ?g. }

• W1489925511 endingPage "49" @default.
• W1489925511 startingPage "29" @default.
• W1489925511 abstract "Both enhanced vascular permeability and angiogenesis of tumor sustain rapid growth of tumor involving many vascular mediators and high vascular density. On the contrary, however, they can be utilized for macromolecular drug delivery to tumor. Impaired reticuloendothelial/lymphatic clearance of macromolecules from the tumor, or lack of such clearance, is another unique characteristic of tumor tissue, which results intratumor retention of macromolecular drugs thus delivered (Figure 1). Consequently, enhanced permeability and retention (EPR) effect is the basis for the selective targeting of macromolecular drugs to tumor, and the EPR concept is now utilized for selective delivery of many macromolecular anticancer agents in aqueous formation for i.v. or i.a. as well as oily formation for i.a. dosing, which is not possible for low-molecular-weight drugs because of rapid washout by capillary vascular blood flow. This EPR concept has been validated in clinical settings with hepatoma and other solid tumors. In our laboratories, several promising macromolecular anticancer drugs after SMANCS, such as PEG-XO, PEG-DAO, PEG-ZnPP, were developed, warranting further investigation for clinical application. More efficient drug delivery to tumor, especially of macromolecular drugs, may be possible by enhancing the EPR effect with the use of various vascular permeability mediators or potentiators. Suppression of the EPR effect by the use of appropriate inhibitors or antidotes, such as the bradykinin antagonist HOE 140 and protease inhibitors or NOS inhibitors, may also be possible. Thus, one may be able to suppress or retard tumor growth and tumor metastasis. Also, by suppressing vascular permeability with antidotes such as the bradykinin antagonist HOE 140, pleural fluid in lung cancer and ascitic fluid in abdominal carcinomatosis may be controlled and the clinical course of cancer patients may be improved. In summary, tumor vasculature can be an excellent target for delivery of macromolecular anticancer drugs; the most beneficial class of drugs in view of tumor-selective targeting based on the EPR effect in solid tumor as well as compliance of patients and ultimate therapeutic efficacy." @default.
• W1489925511 created "2016-06-24" @default.
• W1489925511 creator A5009753049 @default.
• W1489925511 creator A5019215364 @default.
• W1489925511 creator A5080816054 @default.
• W1489925511 date "2005-12-11" @default.
• W1489925511 modified "2023-09-23" @default.
• W1489925511 title "Factors and Mechanism of “EPR” Effect and the Enhanced Antitumor Effects of Macromolecular Drugs Including SMANCS" @default.
• W1489925511 cites W157582816 @default.
• W1489925511 cites W1592797175 @default.
• W1489925511 cites W1964044673 @default.
• W1489925511 cites W1966884476 @default.
• W1489925511 cites W1972992205 @default.
• W1489925511 cites W1981422827 @default.
• W1489925511 cites W1983251348 @default.
• W1489925511 cites W1983387455 @default.
• W1489925511 cites W1983763042 @default.
• W1489925511 cites W1998713301 @default.
• W1489925511 cites W2001499176 @default.
• W1489925511 cites W2001878542 @default.
• W1489925511 cites W2002154317 @default.
• W1489925511 cites W2007747310 @default.
• W1489925511 cites W2012636494 @default.
• W1489925511 cites W2015447656 @default.
• W1489925511 cites W2022518209 @default.
• W1489925511 cites W2025745507 @default.
• W1489925511 cites W2025919388 @default.
• W1489925511 cites W2028211453 @default.
• W1489925511 cites W2043863730 @default.
• W1489925511 cites W2044192395 @default.
• W1489925511 cites W2045789731 @default.
• W1489925511 cites W2049827480 @default.
• W1489925511 cites W2051717913 @default.
• W1489925511 cites W2054728198 @default.
• W1489925511 cites W2057508479 @default.
• W1489925511 cites W2057677923 @default.
• W1489925511 cites W2059032684 @default.
• W1489925511 cites W2062594120 @default.
• W1489925511 cites W2062942901 @default.
• W1489925511 cites W2069072174 @default.
• W1489925511 cites W2078115188 @default.
• W1489925511 cites W2078516817 @default.
• W1489925511 cites W2082712100 @default.
• W1489925511 cites W2088485083 @default.
• W1489925511 cites W2107665428 @default.
• W1489925511 cites W2126692421 @default.
• W1489925511 cites W2133703069 @default.
• W1489925511 cites W2141415623 @default.
• W1489925511 cites W218505100 @default.
• W1489925511 cites W2323366608 @default.
• W1489925511 cites W4233820214 @default.
• W1489925511 cites W4245635197 @default.
• W1489925511 doi "https://doi.org/10.1007/0-306-47932-x_2" @default.
• W1489925511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12675206" @default.
• W1489925511 hasPublicationYear "2005" @default.
• W1489925511 type Work @default.
• W1489925511 sameAs 1489925511 @default.
• W1489925511 citedByCount "191" @default.
• W1489925511 countsByYear W14899255112012 @default.
• W1489925511 countsByYear W14899255112013 @default.
• W1489925511 countsByYear W14899255112014 @default.
• W1489925511 countsByYear W14899255112015 @default.
• W1489925511 countsByYear W14899255112016 @default.
• W1489925511 countsByYear W14899255112017 @default.
• W1489925511 countsByYear W14899255112018 @default.
• W1489925511 countsByYear W14899255112019 @default.
• W1489925511 countsByYear W14899255112020 @default.
• W1489925511 countsByYear W14899255112021 @default.
• W1489925511 countsByYear W14899255112022 @default.
• W1489925511 countsByYear W14899255112023 @default.
• W1489925511 crossrefType "book-chapter" @default.
• W1489925511 hasAuthorship W1489925511A5009753049 @default.
• W1489925511 hasAuthorship W1489925511A5019215364 @default.
• W1489925511 hasAuthorship W1489925511A5080816054 @default.
• W1489925511 hasConcept C113045295 @default.
• W1489925511 hasConcept C142724271 @default.
• W1489925511 hasConcept C178790620 @default.
• W1489925511 hasConcept C185592680 @default.
• W1489925511 hasConcept C2779820397 @default.
• W1489925511 hasConcept C2780035454 @default.
• W1489925511 hasConcept C502942594 @default.
• W1489925511 hasConcept C71924100 @default.
• W1489925511 hasConcept C98274493 @default.
• W1489925511 hasConceptScore W1489925511C113045295 @default.
• W1489925511 hasConceptScore W1489925511C142724271 @default.
• W1489925511 hasConceptScore W1489925511C178790620 @default.
• W1489925511 hasConceptScore W1489925511C185592680 @default.
• W1489925511 hasConceptScore W1489925511C2779820397 @default.
• W1489925511 hasConceptScore W1489925511C2780035454 @default.
• W1489925511 hasConceptScore W1489925511C502942594 @default.
• W1489925511 hasConceptScore W1489925511C71924100 @default.
• W1489925511 hasConceptScore W1489925511C98274493 @default.
• W1489925511 hasLocation W14899255111 @default.
• W1489925511 hasLocation W14899255112 @default.
• W1489925511 hasOpenAccess W1489925511 @default.
• W1489925511 hasPrimaryLocation W14899255111 @default.
• W1489925511 hasRelatedWork W2069859065 @default.
• W1489925511 hasRelatedWork W2125138090 @default.

• next